An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Dae Won Jun
Clin Mol Hepatol. 2021;27(3):446-447.   Published online 2021 May 21     DOI: https://doi.org/10.3350/cmh.2021.0133
Citations to this article as recorded by Crossref logo
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology.2023; 29(Suppl): S184.     CrossRef
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 371.     CrossRef
Risk factors in nonalcoholic fatty liver disease
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(Suppl): S79.     CrossRef
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
Jung Hwan Yu, Han Ah Lee, Seung Up Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S136.     CrossRef
Advances in genetic variation in metabolism-related fatty liver disease
Fan Shi, Mei Zhao, Shudan Zheng, Lihong Zheng, Haiqiang Wang
Frontiers in Genetics.2023;[Epub]     CrossRef
Fatty liver disease: An updated overview of risk factors
Abdullatif Suliman Alsayegh, Mohammed Abdullah Alduaybi, Hamoud Ghayyadh Alanizi, Nada Abdulrahman Amer Alajmi, Shahad Mohammed Bin Saeed, Meshal Ibrahim Zaid Al Owias, Adel Awad Al Rashedi, Asma Saad Alqahtani, Bader Sayah Alanezi
International journal of health sciences.2023; 7(S1): 3698.     CrossRef